406 related articles for article (PubMed ID: 24070383)
21. Congenital histiocytosis. A heterogeneous group of diseases, one presenting as so-called congenital self-healing histiocytosis.
Kodet R; Elleder M; De Wolf-Peeters C; Mottl H
Pathol Res Pract; 1991 May; 187(4):458-66. PubMed ID: 1908575
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
Milne P; Bigley V; Bacon CM; Néel A; McGovern N; Bomken S; Haniffa M; Diamond EL; Durham BH; Visser J; Hunt D; Gunawardena H; Macheta M; McClain KL; Allen C; Abdel-Wahab O; Collin M
Blood; 2017 Jul; 130(2):167-175. PubMed ID: 28512190
[TBL] [Abstract][Full Text] [Related]
23. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
[TBL] [Abstract][Full Text] [Related]
24. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports.
Patrizi A; Neri I; Bianchi F; Guerrini V; Misciali C; Paone G; Burnelli R
Dermatology; 2004; 209(1):57-61. PubMed ID: 15237270
[TBL] [Abstract][Full Text] [Related]
25. Clinical spectrum of histiocytic tumors of the orbit.
Shields JA; Shields CL
Trans Pa Acad Ophthalmol Otolaryngol; 1990; 42():931-7. PubMed ID: 2084989
[TBL] [Abstract][Full Text] [Related]
26. [Reactive and neoplastic histiocytic diseases in the dog].
Schwens Ch; Thom N; Moritz A
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2011; 39(3):176-90. PubMed ID: 22143627
[TBL] [Abstract][Full Text] [Related]
27. Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease.
Conley A; Manjila S; Guan H; Guthikonda M; Kupsky WJ; Mittal S
Neuropathology; 2010 Dec; 30(6):634-47. PubMed ID: 20337948
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
[TBL] [Abstract][Full Text] [Related]
29. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
30. Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells.
Ravindran A; Dasari S; Ruan GJ; Artymiuk CJ; He R; Viswanatha DS; Abeykoon JP; Zanwar S; Young JR; Goyal G; Go RS; Rech KL;
Mod Pathol; 2023 Oct; 36(10):100268. PubMed ID: 37406859
[TBL] [Abstract][Full Text] [Related]
31. Cell(s) of Origin of Langerhans Cell Histiocytosis.
Collin M; Bigley V; McClain KL; Allen CE
Hematol Oncol Clin North Am; 2015 Oct; 29(5):825-38. PubMed ID: 26461145
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages.
Durham BH
Semin Cell Dev Biol; 2019 Feb; 86():62-76. PubMed ID: 29526544
[TBL] [Abstract][Full Text] [Related]
33. Spumous histiocytic oligoarthritis coexisting with systemic Langerhans' cell histiocytosis: case report and literature review.
Aouba A; Larousserie F; Le Guern V; Martin A; Guillevin L
Joint Bone Spine; 2009 Dec; 76(6):701-4. PubMed ID: 19640768
[TBL] [Abstract][Full Text] [Related]
34. [Generalized eruptive histiocytosis-Juvenile xanthogranuloma: clinical spectrum in a pediatric patient].
Alperovich R; Grassino PT; Asial R; Pasteris L; Boente MD
Arch Argent Pediatr; 2017 Apr; 115(2):e116-e119. PubMed ID: 28318197
[TBL] [Abstract][Full Text] [Related]
35. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
Haroche J; Abla O
Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
[TBL] [Abstract][Full Text] [Related]
36. Solitary and generalized variants of spindle cell xanthogranuloma (progressive nodular histiocytosis).
Zelger BW; Staudacher C; Orchard G; Wilson-Jones E; Burgdorf WH
Histopathology; 1995 Jul; 27(1):11-9. PubMed ID: 7557901
[TBL] [Abstract][Full Text] [Related]
37. [Histiocytoses: General classification and molecular criteria].
Emile JF; Charlotte F; Chassagne-Clement C; Copin MC; Fraitag S; Mokhtari K; Moreau A
Presse Med; 2017 Jan; 46(1):46-54. PubMed ID: 26952138
[TBL] [Abstract][Full Text] [Related]
38. Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.
Allen CE; Parsons DW
Hematology Am Soc Hematol Educ Program; 2015; 2015():559-64. PubMed ID: 26637772
[TBL] [Abstract][Full Text] [Related]
39. Novel histiocytoses considered in the context of histiocyte subset differentiation.
Wood GS; Haber RS
Arch Dermatol; 1993 Feb; 129(2):210-4. PubMed ID: 7679570
[No Abstract] [Full Text] [Related]
40. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
